Related Experiment Videos
Management options for primary hepatocellular carcinoma. An overview
1Department of Surgery, Athens Medical Center, Greece.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1994
Summary
Hepatocellular carcinoma (HCC) is a common cancer with numerous risk factors and poor prognosis. Current treatments like surgery offer limited survival benefits, highlighting the need for better therapeutic strategies.
Area of Science:
- Oncology
- Hepatology
- Gastroenterology
Background:
- Hepatocellular carcinoma (HCC) is a prevalent cancer globally, ranking seventh in men and ninth in women.
- Numerous risk factors are linked to HCC development, including viral hepatitis, alcohol abuse, and genetic predispositions.
- HCC diagnosis relies on clinical, laboratory, radiographic, and histopathologic data.
Purpose of the Study:
- To review the epidemiology, risk factors, diagnosis, and treatment of Hepatocellular Carcinoma (HCC).
- To discuss current therapeutic options and their limitations for HCC management.
Main Methods:
- Review of epidemiological studies identifying HCC risk factors.
- Analysis of diagnostic criteria for HCC.
- Evaluation of current treatment modalities for HCC.
Main Results:
- HCC affects a significant portion of the global population annually.
- Established risk factors include hepatitis B/C, alcohol, and genetic conditions.
- Median survival for HCC is poor (3-6 months), with surgical resection as the primary treatment.
Conclusions:
- HCC remains a challenging malignancy with limited treatment efficacy and poor survival rates.
- While surgical resection is standard, other methods like TACE and PEI lack robust evidence.
- Further randomized controlled trials are essential to evaluate combination therapies and optimize HCC patient selection for liver transplantation.